Stocktoria

Black Hawk Acquisition Corp BKHA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-03-21

Black Hawk Acquisition Corp statistics & valuation

Market cap$49.5M
P / E37.2×
Return on capital-4.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
20242025
Shares outstanding
20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
2.70% 5.60% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets5.6%2.7%
Return on equity-34.6%-88.2%
Current ratio0.034.42

Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.